At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 17, 2026 at 15:04 ET
Two Elevance Health insiders, including CEO Gail Boudreaux, made open-market purchases totaling $1.37M over two days following the Q2 2026 earnings release. The CEO bought $1.0M worth of shares, and a director bought $366K. However, the total purchase amount represents only ~0.0017% of ELV's $81B market cap, making it a trivial signal.
- CEO Gail Boudreaux purchased 2,725 shares at ~$367.50 avg, totaling $1,002,230
- Director Ramiro G. Peru purchased 1,000 shares at $366.05, totaling $366,050
- Total insider purchases: $1,368,280, or 0.0017% of $81B market cap
- Purchases occurred 2 days after Q2 2026 earnings (EPS beat by 20%, but revenue growth flat and margins compressed)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access